Does Dr. MAI ABOUELSAAD have financial conflicts of interest?

Dr. MAI ABOUELSAAD (M.D.) has received a total of $952 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $952 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MAI ABOUELSAAD?

According to CMS Open Payments data, Dr. MAI ABOUELSAAD received funding from MALLINCKRODT HOSPITAL PRODUCTS ($245), TRAVERE THERAPEUTICS ($209), and BAYER HEALTHCARE PHARMACEUTICALS ($131).

Does Dr. MAI ABOUELSAAD receive research grants or speaking fees?

Dr. MAI ABOUELSAAD has received $952 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MAI ABOUELSAAD

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: HOUSTON, TX 77089

NPI Number: 1790168086

LIFETIME INDUSTRY VALUE

$952

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOUELSAAD is a verified Internal Medicine, Nephrology practitioner based in HOUSTON, TX.

Between 2021 and 2024, Dr. ABOUELSAAD had an overall industry promotional and research financial footprint of $952 as recorded in the federal CMS Open Payments database.

$952 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOUELSAAD's primary funding source is MALLINCKRODT HOSPITAL PRODUCTS, which accounts for $245 (representing 25.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MALLINCKRODT HOSPITAL PRODUCTS

Rank 1

$245

25.7%

TRAVERE THERAPEUTICS

Rank 2

$209

22%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 3

$131

13.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.